STERIGENICS DENMARK A/S: Financial statements 2025
CVR: 26299691
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
STERIGENICS DENMARK A/S (CVR 26299691) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 45,023,268 and a net result of DKK 24,334,784 compared with DKK 25,507,602 the year before. That is an increase of 1.4% compared with the year before. Equity in the 2025 report amounted to DKK 44,335,784. The solvency ratio was 86.8%. The company had 43 employees in the financial year.
- Gross Profit
- DKK 45,023,268
- Profit/Loss
- DKK 24,334,784
- Equity
- DKK 44,335,784
- Total Assets
- DKK 51,102,120
- Employees
- 43
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 45M | 24.3M | 44.3M | 43 |
| 2024 | - | 44.4M | 25.5M | 68.9M | 45 |
| 2023 | - | 34M | 19M | 121.7M | 42 |
| 2022 | - | 37M | 20.8M | 102.7M | 40 |
| 2021 | - | 33.2M | 19.8M | 81.9M | 33 |
Official annual report
How creditworthy is STERIGENICS DENMARK A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of July 18, 2025, Robin Van Der Bergh has joined the board of directors of STERIGENICS DENMARK A/S.
As of July 18, 2025, Ronald Victor Asselberghs has joined the board of directors of STERIGENICS DENMARK A/S.
As of July 18, 2025, Lars Pontus Rundström has left the board of directors of STERIGENICS DENMARK A/S.
As of July 17, 2025, Robin Van Der Bergh has left the board of directors of STERIGENICS DENMARK A/S.
STERIGENICS DENMARK A/S has published its annual report for 2024. Gross profit came to DKK 44,413,648, and the net result was DKK 25,507,602.
About STERIGENICS DENMARK A/S
STERIGENICS DENMARK A/S is a Danish company of the type Aktieselskab based in Espergærde, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named IBA S&I (DENMARK) A/S. The management consists of Maja Nøddekær. The board consists of Robin Van Der Bergh (chair), Maja Nøddekær and Ronald Victor Asselberghs. The company is owned by Nelson Labs BV. The company has 51 employees (2026). In 2025, the company reported a gross profit of DKK 45,023,268 and a net result of DKK 24,334,784 compared with DKK 25,507,602 the year before. Equity in the 2025 report amounted to DKK 44,335,784.